Risks highest for heart-failure patients soon after index hospitalization

Reuters Health - 19/11/2020 - Patients with chronic, worsening heart failure (HF) have the highest risk of cardiovascular (CV) death or repeat hospitalization soon after their index heart-failure hospitalization (HFH), according to a new analysis of data from the VICTORIA trial. That trial (https://bit.ly/38S5DeO) found that patients with an ejection fraction of less than 45% who were randomized to a target dose of 10 mg vericiguat daily had a lower risk of CV death and HFH than those who received placebo. All patients were also receiving guideline-directed therapies for HF. In the new study, the authors compared outcomes in three subgroups of VICTORIA participants based on index HF event: 3,378 patients who had HFH within the previous three months; 871 who were enrolled within three to six months of HFH; and 801 patients who received outpatient intravenous diuretics for worsening HF in t...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 19 November, 202026 November, 2020